Data de publicação: 18/06/2021 - 16:49
A study by Public Health England (PHE) showed that applying two doses of the AstraZeneca vaccine results in 92% effectiveness against hospitalization due to the Delta (B.1.617.2) variant of the Sars-CoV-2. The variant, formerly known as the Indian variant, has been spreading through the United Kingdom like wildfire and there have been confirmed cases in Brazil as well. The vaccine has also shown high effectiveness against the Alpha (B.1.1.7)...
Notícias
Data de publicação: 24/05/2021 - 17:32
Beatriz Grinsztejn, head of the INI’s Laboratory of Clinical Research on STDs and AIDS, was granted last Wednesday (March 19) the Ward Cates Spirit Award by the HIV Prevention Tests Network (HPTN). Anthony Fauci, director of the National Institute of Allergies and Infectious Diseases (NIAID) of the United States, attended the event.
The award was given by Myron Cohen, the main investigator of the network. More than one thousand...
Notícias
Data de publicação: 31/05/2021 - 10:16
This Wednesday (26/5), at a Deliberative Session at the Plenary, the Chamber of Deputies approved Bill 2077/2019 that establishes the title of Public Health National Heritage and awards it to Fiocruz. The title is granted to governmental and private non-profit institutions who provide relevant and remarkable services to public health and that have technical, scientific, educational, wellfare activities, activities of social participation,...
Notícias
Data de publicação: 09/06/2021 - 09:40
The Bulletin of the Fiocruz COVID-19 Observatory, released last Friday (June 4th), concluded there is a rising trend for Severe Acute Respiratory Syndrome (SARS) in 12 states, in addition to the Federal District, in epidemiological week 21, between May 23rd and 29th. All regions have worrying figures, mainly those in the South and in the Central-West Brazilian regions. About 96% of SARS cases are caused by the new coronavirus.
The relation...
Notícias
Data de publicação: 28/05/2021 - 11:43
In a paper published (5/25) on Nature Medicine, researchers of the Fiocruz Genomic Network and of partner institutions point to the cause of the increase in the number of COVID-19 cases in the state of Amazonas and of the successive replacements of lineages of Sars-CoV-2. The study shows that these factors have been boosted by a combination of reduced social distancing measures and the appearance of a new, more transmissible form of the virus,...
Notícias
Data de publicação: 19/05/2021 - 10:50
The dengue virus is one of the greatest threats to public health in globe tropical regions, and especially in Brazil, where annual epidemics lead to thousands of Brazilians sickness. In the year 2019 alone, there were 2.1 million cases. However, something very intriguing happened in the years 2017-2018, right after the zika, dengue and chikungunya virus’s triple epidemic in 2016. Dengue fever case numbers were reported well below average...
Notícias
Data de publicação: 25/01/2021 - 12:53
In a partnership with the Amazonas Foundation for Health Surveillance (FVS-AM), researchers of the Leônidas and Maria Deane Institute (ILMD/Fiocruz Amazon) have confirmed the second case of reinfection by the Sars-CoV-2 in Brazil. The reinfection occurred in manaus, capital of the state of Amazonas, by the new variant identified in the state, designateed B.1.1.28.1 or P.1. The case was confirmed by virologist and researcher Felipe Naveca....
Notícias
Data de publicação: 08/03/2021 - 18:31
In a technical release issued last Thursday (March 3) by the Fiocruz Covid-19 Observatory, researchers warn of the geographical dispersion, in the territory, of “worrying variants” and of their high prevalence in the three Brazilian regions under study (South, South-East and North-East).
The new RT-PCR protocol, developed by Fiocruz Amazônia, was used by Fiocruz diagnostic support units and testing stations...
Notícias
Data de publicação: 10/03/2021 - 12:53
Many affluent countries, with the necessary technological capabilities and expertise, entered into the production of Covid-19 vaccines or sought the biopharmaceutical companies to block them for themselves through anticipated buying. It is estimated that as early December 2020, 3.8 billion vaccine doses had been guaranteed to these countries by several producers. If one compares that figure with the 3.2 billion doses, that include the 700...
Notícias
Data de publicação: 10/03/2021 - 18:21
Fiocruz president, Nísia Trindade Lima, participated in a World Health Organization (WHO) discussion on how investing in research on Covid-19 treatments can increase cooperation at national and international levels, on March 3. The discussion table, named Towards a Shared Research Agenda, included in the debate on how to identify knowledge gaps and research priorities for COVID-19 treatments, to incentivize cooperation and...
Notícias
Data de publicação: 12/03/2021 - 11:49
In an extraordinary edition of its Bulletin, the Covid-19 Fiocruz Observatory publishes an updated of the historical series on the occupation of COVID-19 ICU beds for adults in the Brazilian Health System (SUS, in the Portuguese acronym), with data obtained on Monday (8/3). The analysis presents rates verified since July 17th, 2020, and aims to alert to the critical scenario of the country. Check out the full document (in Portuguese)....
Notícias
Data de publicação: 15/03/2021 - 11:54
The Brazilian Health Regulatory Agency (Anvisa) granted the definitive registration of the COVID-19 Fiocruz vaccine on March 12. Thus, Fiocruz becomes the first holder of a registration of a COVID -19 vaccine produced in the country and adds to its product portfolio the eleventh vaccine to be supplied to the National Immunization Program (PNI). With the registration, the expectation is that Anvisa will authorize the release of the...
Notícias
Data de publicação: 15/03/2021 - 14:20
On March 11, one year since the World Health Organization (WHO) declared that the COVID-19 epidemic represented a global pandemic, the new Bulletin of the COVID-19 Observatory Fiocruz highlights that Brazil is among the countries with the worst indicators. The country totals 11,122,429 cases and 268,370 deaths, which corresponds to 9.5% and 10.3% of the global total, respectively, even though the Brazilian population is less than 3% of the world...
Notícias
Data de publicação: 17/03/2021 - 09:46
Faced with the current pandemic scenario, Fiocruz released this Tuesday (March 16), another edition of the Fiocruz COVID-19 Observatory Extraordinary Bulletin. The analysis draws attention to the indicators that point to an extremely critical situation across the country. In the view of the researchers who carry it out, this is the biggest health system collapse in the history of Brazil.
The Bulletin shows that, at the moment, of the...
Notícias
Data de publicação: 18/03/2021 - 10:39
Six years after the National Health Emergency declared by the Brazilian Ministry of Health, Zika is still a public health issue that mobilizes many actors in society. Fiocruz is launching the virtual exhibition Zika: lives affecting lives, produced by the Zika Social Sciences Network and the Oswaldo Cruz House (COC/Fiocruz), through the Museum of Life. The exhibition is the result of collaborative scientific research, produced with intense...
Notícias
Data de publicação: 01/04/2021 - 10:02
The Bulletin of the Fiocruz Covid-19 Observatory, released on March 26, shows that the country is facing the collapse of the health system. At the same time, the pandemic is now taking up new shapes, affecting younger age groups: 30 to 39 years old, 40 to 49, and 50 to 59. In such a scenario, researchers defend the adoption of measures in two interconnected groups.
The first group includes urgent measures that involve the containment of the...
Notícias
Data de publicação: 06/04/2021 - 09:24
With the start of Oxford/AstraZeneca-Fiocruz production vaccine on national territory, and the batches delivery to the Ministry of Health, this stage is beginning to give its first results to Brazilian society. Still this year, the country will have a vaccine produced entirely in Brazil and already in this first semester the manufacture of the first batches of the active pharmaceutical ingredient (API) will start, which should be available to...
Notícias
Data de publicação: 09/04/2021 - 09:08
A paper to be published in May in the U.S. Centers for Disease Control and Prevention's (CDC/US) journal Emerging Infectious Diseases (EID) shows that a first exposure to COVID-19 in mild or asymptomatic cases may not produce an immune response, and that a person can reinfect himself or herself with the same variant. The second infection can cause stronger symptoms than the first, the study indicates.
(Photo:Isabela Carrari -...
Notícias
Data de publicação: 12/04/2021 - 12:42
A methodology that aims to make the monitoring of the new coronavirus variants simpler and faster, besides being cheaper, has just been developed at Fiocruz Pernambuco. It is based on a technique that is already widely used and available in Brazil and in the world, the Sanger sequencing - also called sequencing by capillary electrophoresis. The article with this finding has just been made available online as a preprint on the MedRxiv platform....
Notícias
Data de publicação: 12/04/2021 - 18:06
After 6 years of the epidemic that put Northeast Brazil in its epicenter, the Zika virus and its consequences may be away from the spotlight, but it is still a burden that needs to be addressed. From March 15th to18th, researchers from the four corners of the world who participated in one of the greatest Zika research consortiums gathered virtually (due to the current pandemic) to discuss its results and ways forward. The event marked the...
Notícias
Data de publicação: 14/04/2021 - 18:22
Many viruses can hamper coagulation, including those that cause dengue fever and yellow fever. In more severe cases, they may lead to bleeding. This is why these diseases are considered hemorrhagic viral fevers. In a paper recently published in the science magazine “Memórias do Instituto Oswaldo Cruz”, a group of ten researchers argues that the new coronavirus (SARS-CoV-2) should be the first agent recognized as acting in the...
Notícias
Data de publicação: 15/04/2021 - 09:44
The Conference On Expanding Africa’s Vaccine, organized by the African Union and the Centers for Disease Control in Africa (CDC Africa), held on 12 and 13/4, had the Oswaldo Cruz Foundation (Fiocruz) president as one of the speakers on Tuesday. During Session 8, on the Partnership with Foundations for Vaccine Production, Nísia reaffirmed Fiocruz's commitment to a South-South agenda to support the needs of the African continent...
Notícias
Data de publicação: 20/04/2021 - 15:24
The emergence of COVID-19 and the entire context of the pandemic humankind has been facing has raised an alert for the possible appearance of other emerging and re-emerging epidemics that may occur as a consequence of the interferences suffered by Brazilian biomes — deforestation and destruction of ecosystems. In a paper published recently in Genetics and Molecular Biology, researchers highlight that the Amazon’s environmental...
Notícias
Data de publicação: 29/04/2021 - 18:08
Two drugs used against hepatitis C have been proven effective in inhibiting Sars-CoV-2 replication in cells in laboratory studies. The trial is now entering its phase 2: tests in patients. The results of the first phase of the trial, led by researchers of the Oswaldo Cruz Foundation (Fiocruz), were published on April 21 in a paper for the Journal of Antimicrobial Chemotherapy, by Oxford Academic. The results of phase 2 will likely be known in...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
